Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States: Influence of Hospital Volume
- Badheka, Apurva O
- Chothani, Ankit
- Mehta, Kathan
- Patel, Nileshkumar J
- Deshmukh, Abhishek
- Hoosien, Michael
- Shah, Neeraj
- Singh, Vikas
- Grover, Peeyush
- Savani, Ghanshyambhai T
- Panaich, Sidakpal S
- Rathod, Ankit
- Patel, Nilay
- Arora, Shilpkumar
- Bhalara, Vipulkumar
- Coffey, James O
- O'Neill, William
- Makkar, Raj
- Grines, Cindy L
- Schreiber, Theodore
- Natale, Andrea
- Viles Gonzalez, Juan F.
- DI BIASE, LUIGI
Publication date
January 2014
DOI Publisher
Ovid Technologies (Wolters Kluwer Health)Abstract
-Safety data on percutaneous left atrial appendage (LAA) closure arises from centers with considerable expertise in the procedure or from clinical trial, which might not be reproducible in clinical practice. We sought to estimate the frequency and predictors of adverse outcomes and costs of percutaneous LAA closure procedure in the US
Add to ORKG